| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $4.50B | +16.6% |
| Gross profit | $1.63B | — |
| Operating income | $0.70B | — |
| Net income | $0.61B | +21.8% |
| Gross margin | 36.1% | Net margin 13.5% |
| Revenue Q/Q | +8.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $2.88B | 63.9% |
| R&D | $0.30B | 6.6% |
| SG&A | $0.61B | 13.5% |
| Tax & other | $0.09B | 2.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
CPAY ・ CTVA ・ CSGP ・ COST ・ CRH ・ CRWD ・ CCI ・ CSX ・ CMI ・ CVS ・ DHR ・ DRI
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies